- Achieves Net Sales of $19.1 Million -
- Income Before Taxes Improves $14.8 Million Over Prior Year
Period -
- EPS of $0.02; $0.09 Prior to Deemed Dividend on Repurchased
Series A Preferred -
- Questcor Repurchases $16 Million of Preferred and Common Stock
in the Quarter -
- Revised Distribution Agreement to Generate Favorable Impact on
Operating Results -
- Conference Call Today at 11:00 AM ET -
WASHINGTON, Aug. 8 (UPI) -- Brand name drug prices rose 7.4 percent in 2007, but some U.S. drug prices have jumped more than 1,000 percent, researchers said.